{"transactions":[{"id":2227162,"issuer":{"id":109081,"kind":"organization","name":"Baudax Bio, Inc.","symbol":"BXRX"},"owners":[{"id":126037,"kind":"person","name":"Drechsler Andrew T","position":1,"cik":"0001324734","reported_name":"Drechsler Andrew T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-17T16:12:15.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":39473,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") is the economic equivalent of one share of Baudax Bio, Inc. (the \"Company\") common stock, and may be settled, at the Company's option, in cash, shares of common stock, or a combination thereof. The RSUs vest in full on June 15, 2023, subject to continued service with the Company through the vesting date. Upon vesting, if settled in cash, each RSU will entitle the grantee to a cash-payment equal to the \"Fair Market Value\" (as defined in the Company's 2019 Equity Incentive Plan) of one share of the Company's common stock on the vesting date."}],"balance_after":41656,"source":{"system":"sec-edgar","filing":"0001062993-22-015128","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1324734/000106299322015128/form4.xml","form_type":"4"}},{"id":2712401,"issuer":{"id":12101,"kind":"organization","name":"Provention Bio, Inc.","symbol":"PRVB"},"owners":[{"id":126037,"kind":"person","name":"Drechsler Andrew T","position":1,"cik":"0001324734","reported_name":"Drechsler Andrew T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-05-14T19:37:32.000Z","date":"2021-05-12","kind":"grant","acquired":true,"shares":139500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The securities were granted pursuant to the Issuer's Amended and Restated 2017 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"69,750 of the options granted will vest as follows: 25% will vest and become exercisable on May 12, 2022 and 75% will vest and become exercisable monthly over 36 months such that these options will be fully vested and exercisable on May 12, 2025. The remaining 69,750 of the options granted will vest and become exercisable, if at all, in three equal installments of 23,250 options, with each such installment triggered upon the achievement of one of three separate corporate performance milestones prior to or during the year 2024."}],"balance_after":139500,"derivative":{"exercise_price":6.8,"expiration_date":"2031-05-12","underlying":"Common Stock, par value $0.0001","underlying_shares":139500},"source":{"system":"sec-edgar","filing":"0001493152-21-011577","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1695357/000149315221011577/ownership.xml","form_type":"4"}},{"id":2752805,"issuer":{"id":109081,"kind":"organization","name":"Baudax Bio, Inc.","symbol":"BXRX"},"owners":[{"id":126037,"kind":"person","name":"Drechsler Andrew T","position":1,"cik":"0001324734","reported_name":"Drechsler Andrew T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-04-08T19:11:21.000Z","date":"2021-04-07","kind":"grant","acquired":true,"shares":83333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option will vest on April 7, 2022."}],"balance_after":83333,"derivative":{"exercise_price":1.24,"expiration_date":"2031-04-07","underlying":"Common Stock","underlying_shares":83333},"source":{"system":"sec-edgar","filing":"0001192482-21-000330","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1324734/000119248221000330/edgar.xml","form_type":"4"}},{"id":2752804,"issuer":{"id":109081,"kind":"organization","name":"Baudax Bio, Inc.","symbol":"BXRX"},"owners":[{"id":126037,"kind":"person","name":"Drechsler Andrew T","position":1,"cik":"0001324734","reported_name":"Drechsler Andrew T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-08T19:11:21.000Z","date":"2021-04-07","kind":"grant","acquired":true,"shares":56452,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"All shares of common stock are represented by unvested restricted stock units that will vest on April 7, 2022. Vested shares will be delivered to the reporting person within 30 days following the vesting date."}],"balance_after":76452,"source":{"system":"sec-edgar","filing":"0001192482-21-000330","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1324734/000119248221000330/edgar.xml","form_type":"4"}},{"id":3041280,"issuer":{"id":12101,"kind":"organization","name":"Provention Bio, Inc.","symbol":"PRVB"},"owners":[{"id":126037,"kind":"person","name":"Drechsler Andrew T","position":1,"cik":"0001324734","reported_name":"Drechsler Andrew T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-09-02T17:00:32.000Z","date":"2020-09-02","kind":"purchase","acquired":true,"shares":2000,"price":11.72,"value":23440.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $11.71 to $11.73, inclusive. The reporting person undertakes to provide to Provention Bio, Inc., any security holder of Provention Bio, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001493152-20-017159","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1695357/000149315220017159/ownership.xml","form_type":"4"}},{"id":3049702,"issuer":{"id":109081,"kind":"organization","name":"Baudax Bio, Inc.","symbol":"BXRX"},"owners":[{"id":126037,"kind":"person","name":"Drechsler Andrew T","position":1,"cik":"0001324734","reported_name":"Drechsler Andrew T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-21T16:20:58.000Z","date":"2020-08-20","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"All of the shares of common stock are represented by restricted stock units that will vest 50% on each of August 20, 2021 and August 20, 2022, subject to continued service through the applicable vesting date."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001192482-20-000691","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1324734/000119248220000691/edgar.xml","form_type":"4"}},{"id":3058725,"issuer":{"id":12101,"kind":"organization","name":"Provention Bio, Inc.","symbol":"PRVB"},"owners":[{"id":126037,"kind":"person","name":"Drechsler Andrew T","position":1,"cik":"0001324734","reported_name":"Drechsler Andrew T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-08-13T19:01:53.000Z","date":"2020-08-13","kind":"purchase","acquired":true,"shares":1750,"price":13.01,"value":22767.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.00 to $13.02, inclusive. The reporting person undertakes to provide to Provention Bio, Inc., any security holder of Provention Bio, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4."}],"balance_after":18000,"source":{"system":"sec-edgar","filing":"0001493152-20-015601","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1695357/000149315220015601/ownership.xml","form_type":"4"}},{"id":3081844,"issuer":{"id":12101,"kind":"organization","name":"Provention Bio, Inc.","symbol":"PRVB"},"owners":[{"id":126037,"kind":"person","name":"Drechsler Andrew T","position":1,"cik":"0001324734","reported_name":"Drechsler Andrew T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option (right to buy)","published_at":"2020-07-16T18:01:09.000Z","date":"2020-07-15","kind":"grant","acquired":true,"shares":137750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The securities were granted pursuant to the Issuer's Amended and Restated 2017 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"55,100 option shares vest in four equal annual installments commencing on July 15, 2021; the remaining 82,650 options shares vest upon completion of certain performance milestones. The completion of each milestone vests 15% of the total option shares."}],"balance_after":137750,"derivative":{"exercise_price":12.62,"expiration_date":"2030-07-15","underlying":"Common Stock, par value $0.0001","underlying_shares":137750},"source":{"system":"sec-edgar","filing":"0001493152-20-013471","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1695357/000149315220013471/ownership.xml","form_type":"4"}},{"id":3478773,"issuer":{"id":12101,"kind":"organization","name":"Provention Bio, Inc.","symbol":"PRVB"},"owners":[{"id":126037,"kind":"person","name":"Drechsler Andrew T","position":1,"cik":"0001324734","reported_name":"Drechsler Andrew T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option (right to buy)","published_at":"2019-06-25T17:00:12.000Z","date":"2019-06-24","kind":"grant","acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The securities were granted pursuant to the Issuer's Amended and Restated 2017 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"160,000 option shares vest in four equal annual installments commencing on June 24, 2020; the remaining 240,000 options shares vest upon completion of certain performance milestones. The completion of each milestone vests 20% of the total option shares."}],"balance_after":400000,"derivative":{"exercise_price":12.54,"expiration_date":"2029-06-24","underlying":"Common Stock, par value $0.0001","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001493152-19-009703","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1695357/000149315219009703/ownership.xml","form_type":"4"}},{"id":3764783,"issuer":{"id":12101,"kind":"organization","name":"Provention Bio, Inc.","symbol":"PRVB"},"owners":[{"id":126037,"kind":"person","name":"Drechsler Andrew T","position":1,"cik":"0001324734","reported_name":"Drechsler Andrew T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-11-14T20:00:47.000Z","date":"2018-11-13","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on September 11, 2017, pursuant to the Issuer's 2017 Equity Incentive Plan. 216,688 option shares vest in four equal annual installments commencing on September 1, 2018; the remaining 325,032 option shares vest upon completion of certain performance milestones. The completion of each milestone vests 15% of the total option shares."}],"balance_after":531720,"derivative":{"exercise_price":2.5,"expiration_date":"2027-09-10","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001493152-18-016231","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1695357/000149315218016231/ownership.xml","form_type":"4"}},{"id":3764782,"issuer":{"id":12101,"kind":"organization","name":"Provention Bio, Inc.","symbol":"PRVB"},"owners":[{"id":126037,"kind":"person","name":"Drechsler Andrew T","position":1,"cik":"0001324734","reported_name":"Drechsler Andrew T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-11-14T20:00:47.000Z","date":"2018-11-13","kind":"exercise","acquired":true,"shares":10000,"price":2.5,"value":25000.0,"ownership":{"direct":true},"balance_after":16250,"source":{"system":"sec-edgar","filing":"0001493152-18-016231","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1695357/000149315218016231/ownership.xml","form_type":"4"}},{"id":3864585,"issuer":{"id":12101,"kind":"organization","name":"Provention Bio, Inc.","symbol":"PRVB"},"owners":[{"id":126037,"kind":"person","name":"Drechsler Andrew T","position":1,"cik":"0001324734","reported_name":"Drechsler Andrew T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2018-07-19T17:56:21.000Z","date":"2018-07-19","kind":"purchase","acquired":true,"shares":6250,"price":4,"value":25000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The securities were purchased pursuant to an underwritten public offering by the Issuer. The offering closed on July 19, 2018."}],"balance_after":6250,"source":{"system":"sec-edgar","filing":"0001493152-18-010233","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1695357/000149315218010233/ownership.xml","form_type":"4"}},{"id":4405141,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":126037,"kind":"person","name":"Drechsler Andrew T","position":1,"cik":"0001324734","reported_name":"Drechsler Andrew T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2017-03-03T21:17:05.000Z","date":"2017-03-01","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock options granted on November 7, 2012 under the Company's 2000 Stock Incentive Plan. The options became exercisable based on the following vesting schedule: twenty five percent (25%) on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant."}],"balance_after":45145,"derivative":{"exercise_price":6.65,"expiration_date":"2022-11-07","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001127430-17-000017","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000112743017000017/edgar.xml","form_type":"4"}},{"id":4405140,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":126037,"kind":"person","name":"Drechsler Andrew T","position":1,"cik":"0001324734","reported_name":"Drechsler Andrew T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2017-03-03T21:17:05.000Z","date":"2017-03-01","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock options granted on November 7, 2012 under the Company's 2000 Stock Incentive Plan. The options became exercisable based on the following vesting schedule: twenty five percent (25%) on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant."}],"balance_after":74855,"derivative":{"exercise_price":6.65,"expiration_date":"2022-11-07","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001127430-17-000017","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000112743017000017/edgar.xml","form_type":"4"}},{"id":4405139,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":126037,"kind":"person","name":"Drechsler Andrew T","position":1,"cik":"0001324734","reported_name":"Drechsler Andrew T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-03-03T21:17:05.000Z","date":"2017-03-01","kind":"exercise","acquired":true,"shares":10000,"price":6.65,"value":66500.0,"ownership":{"direct":true},"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001127430-17-000017","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000112743017000017/edgar.xml","form_type":"4"}},{"id":4405138,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":126037,"kind":"person","name":"Drechsler Andrew T","position":1,"cik":"0001324734","reported_name":"Drechsler Andrew T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-03-03T21:17:05.000Z","date":"2017-03-01","kind":"sale","acquired":false,"shares":20000,"price":16.51,"value":330200.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $16.46 to $16.74, inclusive."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001127430-17-000017","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000112743017000017/edgar.xml","form_type":"4"}},{"id":4405137,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":126037,"kind":"person","name":"Drechsler Andrew T","position":1,"cik":"0001324734","reported_name":"Drechsler Andrew T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-03-03T21:17:05.000Z","date":"2017-03-01","kind":"exercise","acquired":true,"shares":20000,"price":6.65,"value":133000.0,"ownership":{"direct":true},"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001127430-17-000017","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000112743017000017/edgar.xml","form_type":"4"}},{"id":4549069,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":126037,"kind":"person","name":"Drechsler Andrew T","position":1,"cik":"0001324734","reported_name":"Drechsler Andrew T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option","published_at":"2016-11-18T21:08:23.000Z","date":"2016-11-17","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options granted under the Company's 2000 Stock Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant."}],"balance_after":55145,"derivative":{"exercise_price":6.65,"expiration_date":"2022-11-07","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001127430-16-000162","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000112743016000162/edgar.xml","form_type":"4"}},{"id":4549068,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":126037,"kind":"person","name":"Drechsler Andrew T","position":1,"cik":"0001324734","reported_name":"Drechsler Andrew T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2016-11-18T21:08:23.000Z","date":"2016-11-17","kind":"exercise","acquired":true,"shares":5000,"price":6.65,"value":33250.0,"ownership":{"direct":true},"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001127430-16-000162","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000112743016000162/edgar.xml","form_type":"4"}},{"id":4555461,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":126037,"kind":"person","name":"Drechsler Andrew T","position":1,"cik":"0001324734","reported_name":"Drechsler Andrew T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option","published_at":"2016-11-15T22:07:21.000Z","date":"2016-11-14","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Stock Options granted under the Company's 2000 Stock Incentive Plan. On March 20, 2013, the Reporting Person was granted an option to purchase 50,000 shares of common stock. The option vests in two equal installments based upon the Company's satisfaction of two separate performance metrics. One such performance metric was met by the Company on February 26, 2015, resulting in vesting of the option as to 25,000 shares."}],"balance_after":25000,"derivative":{"exercise_price":6.9,"expiration_date":"2023-03-20","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001127430-16-000158","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000112743016000158/edgar.xml","form_type":"4"}},{"id":4555460,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":126037,"kind":"person","name":"Drechsler Andrew T","position":1,"cik":"0001324734","reported_name":"Drechsler Andrew T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option","published_at":"2016-11-15T22:07:21.000Z","date":"2016-11-14","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock options granted under the Company's 2000 Stock Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant."}],"balance_after":94855,"derivative":{"exercise_price":6.65,"expiration_date":"2022-11-07","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001127430-16-000158","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000112743016000158/edgar.xml","form_type":"4"}},{"id":4555459,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":126037,"kind":"person","name":"Drechsler Andrew T","position":1,"cik":"0001324734","reported_name":"Drechsler Andrew T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2016-11-15T22:07:21.000Z","date":"2016-11-14","kind":"sale","acquired":false,"shares":25000,"price":14.67,"value":366750.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price in column 4 is a weighted average price. The prices actually paid by the Reporting Person in these transactions range from $14.22 to $14.915."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001127430-16-000158","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000112743016000158/edgar.xml","form_type":"4"}},{"id":4555458,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":126037,"kind":"person","name":"Drechsler Andrew T","position":1,"cik":"0001324734","reported_name":"Drechsler Andrew T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2016-11-15T22:07:21.000Z","date":"2016-11-14","kind":"exercise","acquired":true,"shares":25000,"price":6.9,"value":172500.0,"ownership":{"direct":true},"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001127430-16-000158","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000112743016000158/edgar.xml","form_type":"4"}},{"id":4555457,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":126037,"kind":"person","name":"Drechsler Andrew T","position":1,"cik":"0001324734","reported_name":"Drechsler Andrew T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2016-11-15T22:07:21.000Z","date":"2016-11-14","kind":"sale","acquired":false,"shares":20000,"price":14.67,"value":293400.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price in column 4 is a weighted average price. The prices actually paid by the Reporting Person in these transactions range from $14.22 to $14.915."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001127430-16-000158","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000112743016000158/edgar.xml","form_type":"4"}},{"id":4555456,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":126037,"kind":"person","name":"Drechsler Andrew T","position":1,"cik":"0001324734","reported_name":"Drechsler Andrew T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2016-11-15T22:07:21.000Z","date":"2016-11-14","kind":"exercise","acquired":true,"shares":20000,"price":6.65,"value":133000.0,"ownership":{"direct":true},"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001127430-16-000158","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000112743016000158/edgar.xml","form_type":"4"}}]}